RxDoctor Payments Data

Tiffni Daniel, APRN

Psychiatric/Mental Health · Columbus, GANPI 1275103319

Payments from drug & device makers

$1,672in general payments, 2019–2025

Across 91 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$411
  • AbbVie$338
  • Otsuka America Pharmaceutical, Inc.$220
  • Lundbeck LLC$156
  • Teva Pharmaceuticals USA, Inc.$155
  • Indivior Inc.$118
  • plus $274 from 4 others

What the payments were for

  • Food & beverage$1,672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,672 in reported general payments places this provider in the 80th percentile of 900 psychiatric/mental health providers in Georgia.

See all psychiatric/mental health providers in Georgia

Medicare billing

Part B allowed, 2024
$1,683
Medicare patients
15
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate61$172,583
AustedoDeutetrabenazine37$164,654
LybalviOlanzapine/Samidorphan Malate11$16,687
Aripiprazole134$15,373
Oxcarbazepine75$2,428
Quetiapine Fumarate132$2,118
Fluvoxamine Maleate19$1,740
Trazodone Hcl176$1,678
Hydroxyzine Pamoate137$1,586
Olanzapine78$1,511
Fluphenazine Hcl12$1,508
Divalproex Sodium58$1,438
Haloperidol21$1,213
Haloperidol Decanoate15$1,054
Risperidone90$917

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$411$172,58361 claims
Teva Pharmaceuticals USA, Inc.Austedo$155$164,65437 claims
Alkermes, Inc.Lybalvi$106$16,68711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 900 psychiatric/mental health providers in Georgia.

Other psychiatric/mental health in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →